Literature DB >> 12761074

Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Mattias Collin1, Arne Olsén.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761074      PMCID: PMC155735          DOI: 10.1128/IAI.71.6.2983-2992.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  115 in total

1.  Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (Streptococcal proteinase).

Authors:  D Gerlach; W Reichardt; B Fleischer; K H Schmidt
Journal:  Zentralbl Bakteriol       Date:  1994-03

2.  Competent antigen-binding fragments (Fab) from secretory immunoglobulin A using Streptococcus sanguis immunoglobulin A protease.

Authors:  C P Mallett; R J Boylan; D L Everhart
Journal:  Caries Res       Date:  1984       Impact factor: 4.056

3.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

4.  EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Authors:  Mattias Collin; Mikael D Svensson; Anders G Sjöholm; Jens C Jensenius; Ulf Sjöbring; Arne Olsén
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites.

Authors:  J D Doran; M Nomizu; S Takebe; R Ménard; D Griffith; E Ziomek
Journal:  Eur J Biochem       Date:  1999-07

6.  Role of galactosylation in the renal pathogenicity of murine immunoglobulin G3 monoclonal cryoglobulins.

Authors:  T Mizuochi; Y Pastore; K Shikata; A Kuroki; S Kikuchi; T Fulpius; M Nakata; L Fossati-Jimack; L Reininger; M Matsushita; T Fujita; S Izui
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

7.  Novel functions of human alpha(1)-protease inhibitor after S-nitrosylation: inhibition of cysteine protease and antibacterial activity.

Authors:  Y Miyamoto; T Akaike; M S Alam; K Inoue; T Hamamoto; N Ikebe; J Yoshitake; T Okamoto; H Maeda
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

8.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome.

Authors:  D F Talkington; B Schwartz; C M Black; J K Todd; J Elliott; R F Breiman; R R Facklam
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Streptococcal C5a peptidase is a highly specific endopeptidase.

Authors:  P P Cleary; U Prahbu; J B Dale; D E Wexler; J Handley
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more
  22 in total

1.  Binding of alpha2-macroglobulin to GRAB (Protein G-related alpha2-macroglobulin-binding protein), an important virulence factor of group A streptococci, is mediated by two charged motifs in the DeltaA region.

Authors:  Antonia W Godehardt; Sven Hammerschmidt; Ronald Frank; Gursharan S Chhatwal
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  Bacterial proteases disarming host defense.

Authors:  Heiko Herwald; Arne Egesten
Journal:  J Innate Immun       Date:  2008-12-02       Impact factor: 7.349

3.  Ultrahigh and high resolution structures and mutational analysis of monomeric Streptococcus pyogenes SpeB reveal a functional role for the glycine-rich C-terminal loop.

Authors:  Gonzalo E González-Páez; Dennis W Wolan
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

4.  Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies.

Authors:  Beatriz Trastoy; Joseph V Lomino; Brian G Pierce; Lester G Carter; Sebastian Günther; John P Giddens; Greg A Snyder; Thomas M Weiss; Zhiping Weng; Lai-Xi Wang; Eric J Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

Review 5.  The detrimental impact of extracellular bacterial proteases on wound healing.

Authors:  Sharon Lindsay; Angela Oates; Katie Bourdillon
Journal:  Int Wound J       Date:  2017-07-25       Impact factor: 3.315

6.  Role of HtrA in surface protein expression and biofilm formation by Streptococcus mutans.

Authors:  Saswati Biswas; Indranil Biswas
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Regulation of SpeB in Streptococcus pyogenes by pH and NaCl: a model for in vivo gene expression.

Authors:  Jennifer A Loughman; Michael Caparon
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

8.  Role for serine protease HtrA (DegP) of Streptococcus pyogenes in the biogenesis of virulence factors SpeB and the hemolysin streptolysin S.

Authors:  William R Lyon; Michael G Caparon
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  The ScpC protease of Streptococcus pyogenes affects the outcome of sepsis in a murine model.

Authors:  Hong Sjölinder; Lena Lövkvist; Laura Plant; Jens Eriksson; Helena Aro; Allison Jones; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

10.  Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits complement activation and neutrophil opsonophagocytosis.

Authors:  Chih-Feng Kuo; Yee-Shin Lin; Woei-Jer Chuang; Jiunn-Jong Wu; Nina Tsao
Journal:  Infect Immun       Date:  2008-01-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.